|Bid||117.60 x 1000|
|Ask||120.37 x 800|
|Day's range||117.14 - 120.00|
|52-week range||77.69 - 181.07|
|Beta (5Y monthly)||0.50|
|PE ratio (TTM)||N/A|
|Earnings date||05 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||171.42|
REDWOOD CITY, Calif., July 13, 2021--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2021 after market close on Thursday, August 5, 2021. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Guardant Health, Inc. ( NASDAQ:GH ) shareholders might be concerned after seeing the share price drop 22% in the last...
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.